Evidence map›Paper›PMID 8734833›Full record

ArticleCancer causes & control : CCC1996

A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

L S Cook, E White, S M Schwartz, B McKnight, J R Daling, N S Weiss

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Cancer causes & control : CCC, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants inJournal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Histo-biological comparative analysis of bilateral breast cancer.Medical oncology (Northwood, London, England) · 2013
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cancer registries in epidemiologic research.Cancer causes & control : CCC · 1996
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

L S CookDepartment of Epidemiology, University of Washington, Seattle, USA.
E White
S M Schwartz
B McKnight
J R Daling
N S Weiss
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

SURVEILLANCE EPIDEMIOLOGY AND END RESULTSN01CN005230 · CN · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1990 to 1996
–
TAMOXIFEN THERAPY AND RISK OF REPRODUCTIVE CANCERSR03HS008004 · AHRQ · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COOK, LINDA S. · 1993 to 1993
–
RESEARCH IN CANCER EPIDEMIOLOGYR35CA039779 · NCI · UNIVERSITY OF WASHINGTON · PI WEISS, NOEL · 1985 to 1998
–
AHRQ HHS 1 RO3 HS08004-01NCI NIH HHS N01-CN-05230NCI NIH HHS R 35 CA39779
6 · The paper itself

Abstract

To evaluate predictors of contralateral breast cancer risk, we examined data from a nested case-control study of second primary cancers among a cohort of women in western Washington (United States) diagnosed with breast cancer during 1978 through 1990 and identified through a population-based cancer registry. Cases included all women in the cohort who subsequently developed contralateral breast cancer at least six months after the initial diagnosis, but prior to 1992 (n = 234). Controls were sampled randomly from the cohort, matched to cases on age, stage, and year of initial breast cancer diagnosis. Information on potential risk factors for second primary cancer was obtained through medical record abstractions and physician questionnaires. Women who were postmenopausal due to a bilateral oophorectomy (i.e., a surgical menopause) at initial breast cancer diagnosis had a reduction in contralateral breast cancer risk compared with premenopausal women (matched odds ratio [mOR] = 0.25, 95 percent confidence interval [CI] = 0.09-0.68), whereas no reduction in risk was noted among postmenopausal women who had had a natural menopause (mOR = 0.90, CI = 0.39-2.09). Among postmenopausal women, there was a suggestion of a lower risk associated with relatively high parity (2+). A family history of breast cancer was associated with an increased risk (mOR = 1.96, CI = 1.22-5.15) and varied little by menopausal status. Having an initial tumor with a lobular component (c.f. a ductal histology) was not related strongly to risk (mOR = 1.47, CI = 0.79-2.74). The results of the present and earlier studies argue that we have limited ability to predict the occurrence of a contralateral breast tumor. Better predictors will be required before diagnostic and preventive interventions can be targeted to subgroups of patients with unilateral breast cancer.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, LobularCase-Control StudiesCohort StudiesConfidence IntervalsFemaleForecastingHumansMiddle AgedNeoplasms, Second PrimaryNeoplasm StagingOdds Ratio

Identifiers

PMID8734833
OpenAlexW1995859453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.